Rajkumar V. Patil
Chief Scientific Officer · OKYO Pharma Ltd
IndividualBuying only
- 2026
- Aug 7, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Rajkumar V. Patil files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gabriele M. Cerrone - $35K in OKYO purchases and sales in the last 12 months
- Flavio Mantelli - $28K in OKYO purchases and sales in the last 12 months
- Robert John Dempsey - $23K in OKYO purchases and sales in the last 12 months
- John P. Brancaccio - $7K in OKYO purchases and sales in the last 12 months
- Gary S. Jacob - $5K in OKYO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Rajkumar V. Patil?
Rajkumar V. Patil is a corporate insider, tracked as Chief Scientific Officer of OKYO Pharma Ltd (OKYO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Rajkumar V. Patil submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Rajkumar V. Patil been buying or selling stock?
Recorded transactions: 1 open-market purchase ($5K) and 0 open-market sales across all tracked filings.
